"One of the nation's premier plaintiffs' firms."
"Representing the best qualities of the plaintiffs' bar."
The National Law Journal
"Their effective and caring advocacy for clients has earned Lieff Cabraser its first-class reputation."
The Daily Journal
California Pharmaceutical Cases
- Issue: Unfair competition
- Result: Settlement valued at $171 million
Pharmaceutical Cases I, II, and III
Lieff Cabraser served as Co-Lead and Co-Liaison Counsel representing a certified class of indirect purchasers (consumers) on claims against the major pharmaceutical manufacturers for violations of the Cartwright Act and the Unfair Competition Act.
The class alleged that defendants unlawfully fixed discriminatory prices on prescription drugs to retail pharmacists in comparison with the prices charged to certain favored purchasers, including HMOs and mail order houses.
In April 1999, the Court approved a settlement providing $148 million in free, brand-name prescription drugs to health agencies that serve California’s poor and uninsured. In October 2001, the Court approved a settlement with the remaining defendants in the case, which provided an additional $23 million in free, brand-name prescription drugs to these agencies.